|
|

|
QUESTION OF THE WEEK |
|
December 31, 2007
Q "Our
mother died about nine months ago, and our father is a shambles. He does not
seem to get over it, stays alone, does not take care of himself....should we be
worried enough to get help for him?"
A
"Bereavement is associated with an increase in
mortality risk, particularly in the first weeks or months following a loss. A
"broken heart," or the psychological stress following the loss of a loved one,
along with related losses such as changes to living arrangements and economics,
may increase the risk for death in the person who is mourning.
Further, people who have been bereaved are more likely to have physical health
problems, with higher rates of disability, medication use, and hospitalization,
compared with nonbereaved people, they note. However, in most cases,
professional counseling does not improve outcomes for people who are grieving
the loss of a loved one, but rather, most cases of uncomplicated grief will
resolve without intervention.
For most people, the experience, though difficult, is tolerable and abates with
time. For some, however, the suffering is intense and prolonged. Several studies
in Europe and North America have examined excess mortality in relation to
bereavement. One, for example, found a 3.3-fold increase in risk for suicide in
men over 60 years of age who lost their wife, but no such increase in women of
the same age who lost their husband. Another report in 2006 showed that
widowers had a 21% increased risk for all-cause mortality and widows a 17%
increased risk. Risks were further increased in the first 30 days after
bereavement. For parents losing children, a Danish study published in 2003
showed fathers and mothers have an increased risk for suicide after the death of
a child, a risk that is higher with younger children and particularly high in
the first 30 days after bereavement.
Grief is the primarily emotional reaction to the loss of a loved one through
death, is a normal but complex reaction to loss, incorporating diverse
psychological and physical manifestations. For most people, family, friends,
religious and community groups, and various societal resources provide the
necessary support. Professional psychological intervention is generally neither
justified nor effective for uncomplicated forms of grief." Lancet.
2007;370:1960-1973.
December 24, 2007
Q "Did
I hear that depression causes breast cancer?"
A
That would be too great a generalization. This is an area under investigation.
"Depression appears to somewhat heighten the risk of breast cancer, but has no
significant association with lung, colon or prostate cancers.
Depression is related to a slightly increased risk of cancer. The relation with
breast cancer gets stronger with a longer follow-up period."
With the evidence available at this moment, it's difficult to disentangle the
possible effects of depression and antidepressants on the occurrence of
subsequent cancer. With the current knowledge, it not yet possible to translate
these results into preventive interventions.
Clin Prac Epid Mental Health 2007.
December 17, 2007
Q "Did
you read that article about the brain and uncertainty?"
A
You may be referring to this one: "A new study shows
that belief, disbelief, and uncertainty may be distinguishable using functional
neuroimaging. Researchers report that subjects challenged with statements that
were true, false, or undecidable showed activation in distinct regions of the
prefrontal and parietal cortices and the basal ganglia.
These results suggest that the differences among belief, disbelief, and
uncertainty may one day be distinguished reliably, in real time, by techniques
of neuroimaging. This would have obvious implications for the detection of
deception, for the control of the placebo effect during the process of drug
design, and for the study of any higher-cognitive phenomenon in which the
differences among belief, disbelief, and uncertainty might be a relevant
variable.
The difference between believing and disbelieving a proposition is one of the
most potent regulators of human behavior and emotion. When one accepts a
statement as true, it becomes the basis for further thought and action; rejected
as false, it remains a string of words.
When they contrasted the trials of belief vs disbelief, they found increased
signals in the ventromedial prefrontal cortex (VMPFC), which is involved in
linking factual knowledge with emotion. The involvement of the VMPFC in belief
processing suggests an anatomical link between the purely cognitive aspects of
belief and human emotion and reward.
Ethical belief followed a similar pattern of activation to mathematical belief,
they noted, suggesting that the physiological difference between belief and
disbelief is not related to content or emotional associations.
Contrasting disbelief with belief showed increased signals in the anterior
insula, a brain region involved in the sensation of taste, perception of pain,
and the feeling of disgust. Uncertainty evoked a positive signal in the anterior
cingulate cortex and a decreased signal in the caudate, a region of the basal
ganglia that plays a role in motor action. Because both belief and disbelief
were associated with an increased signal in the caudate compared with
uncertainty, the authors suggest that the basal ganglia may play a role in
mediating the cognitive and behavioral differences between decision and
indecision."
Ann Neurol. December 10, 2007.
December 10, 2007
Q "Learning
disorders are due to psychological problems like trauma, right?"
A
Actually, no: "Research implicates defects in brain white matter in impaired
reading fluency, seen both in people with dyslexia and patients with a rare
genetic brain condition called periventricular nodular heterotopia (PNH)
The research could have implications for the type of learning strategies that
might be useful for the estimated 5% to 17% of children who have dyslexia. This
research helps to support the notion that reading fluency has to be considered a
neurobiologically important aspect of reading problems.
There are nodules of misplaced gray matter that contain neurons that should have
migrated out to the surface of the brain and failed to do so.
Even with these large regions of misplaced gray matter, PNH patients appear
outwardly normal. These are individuals who have normal intelligence, normal
attention, normal memory; they typically go through school and work normally.
However, PNH patients do develop seizures, and that is usually how they are
diagnosed.
The study showed that the more the white matter was disorganized in the PNH
patients, the worse their reading fluency.
So white-matter disruptions may explain the difficulty with the "rapid,
automatic, smooth serial processing" that is required for reading. Reading
fluency may have this distinct structural basis in the brain, which may be
different from the structural basis for other aspects of reading difficulty,
like phonological difficulty. Reading fluency problems are particularly
difficult to remediate, more difficult than the typical phonological problems,
and yet many remediation programs focus on phonology."
Neurology. 2007;69;2146-2154.
December 3, 2007
Q
"Too little sleep causes disease right? Then the more sleep the better?"
A
Not necessarily. It depends upon your regular pattern and changes from
that pattern. "Significantly changing normal sleep patterns — either getting
much more or much less sleep — increases the risk for mortality. The study found
that decreasing nightly sleep from 6, 7, or 8 hours doubles the risk for
cardiovascular death, while increasing sleep from 7 or 8 hours doubles the risk
for noncardiovascular death.
If you have a regular pattern — 6, 7, or 8 hours — and you maintain that over
time, that’s protective against premature mortality. If you move out of that to
the 9-hours-or-more category, that seems to increase all-cause mortality and the
group of deaths that increases is the noncardiovascular deaths. If you go to the
short end of the spectrum, you increase your risk for cardiovascular mortality.
The study found a U-shaped association in both phases between sleep and
subsequent all-cause mortality. The link between decreased hours of sleep and
higher cardiovascular mortality risk seems to make some sense: Short sleep
duration is a risk factor for weight gain, insulin resistance, and type 2
diabetes, the authors write. Short sleep is also accompanied by increased
cortisol levels and abnormal growth hormone secretion and has been associated
with hypertension and some cardiovascular diseases.
However, the link between deaths and longer sleep patterns is not as clear. We
really don’t know what’s driving that. Researchers may want to take a look at
the role of increased cancer deaths or trauma deaths among patients changing to
a long sleep pattern.
A significant change in sleep patterns may be a red flag for some underlying
disease, she said. “If somebody comes to you and they’re now reporting having
moved from a normal sleep pattern either to the very short end of the sleep
spectrum or the long end of the sleep spectrum and that appears to be a pattern
that’s continuing over time and is not their regular pattern, then that is
probably a marker of something. Sleep. 2007;30:1659-1666.
November 26, 2007
Q "People
with Alzheimers get very agitated with urinary tract infections...I have read.
Is this an organ system that creates other problems for them from a
psychological standpoint?"
A
"Stroke survivors who develop urinary incontinence are less attentive than
continent patients. Attention-focused training might therefore be helpful in
regaining bladder control.
Compared to continent patients, those with urge UI had poorer power of attention
and speed of memory. However, these patients had similar continuity of attention
to continent subjects. Patients with IA-UI performed worse than continent
patients and those with urge UI in all categories.
Sustained attention seems important for outcome and should be taken into account
in the rehabilitation process. In patients who recognize their incontinence,
attention-focused training might be the most effective measure of reestablishing
bladder control."
J Am Geriatr Soc 2007;55:1571-1577.
November 19, 2007
Q "Is
there not a relationship between heart disease and Alzheimer's Disease, and
could fixing the first, help the last?"
A
Not exactly, but there is a relationship between
medication that lowers cholesterol and its impact upon mental functioning:
"Research links statin use to reduced cognitive decline, but it uncovers a
curious phenomenon: African American patients who stopped taking statins
appeared to reap an even greater cognitive benefit than those who continued
taking this cholesterol-lowering medication....seem to underline the complex
nature of the relationship between statins and dementia prevention.
Statins play an important role in the prevention of cardiovascular disease (CVD),
and given the apparent link between CVD risk factors and risk factors for
cognitive decline, it is possible that statins could also play a role in
prevention of dementia, the authors conclude.
The researchers noted that 25% of the elderly African American sample were using
statins in 2001, perhaps not surprising since African Americans have a higher
prevalence of coronary risk factors than other populations in the United States.
Adjusting for age at baseline, sex, education, and ApoE status, researchers
found less cognitive decline among statin users than among non–statin users.
If statin use reduces cognitive decline, then it is reasonable to assume that
continued use of statins would produce a greater reduction. However, that was
not the case in this study. Researchers found that those who continued to take
statins from 2001 to 2004 had greater cognitive decline than those who were
taking statins in 2001 but were no longer taking them in 2004. Neither the
lipid-lowering nor the anti-inflammatory effects of statins could explain the
effect of statins on cognitive decline.
It is possible that some other mechanism of statins — for example, their
antioxidant effects or protective effect on endothelial dysfunction — is at
work. In addition to lowering lipids in plasma, statins also lower the level of
a major product of brain cholesterol metabolism. Statin use plays an important
role in the prevention of cardiovascular disease...And there may be a link
between cardiovascular risk factors and risk factors for cognitive decline and
Alzheimer's disease."
Neurology 2007;69:1873-1880.
November 12, 2007
Q "Is
it not generally accepted that marijuana is certainly safer than tobacco and, in
general, rather harmless."
A
No, I am afraid that is not accurate. "Prenatal marijuana exposure had
significant effects on the developing central nervous system (CNS) in children
and adolescents. Prenatal and adolescent nicotine exposure was associated with
sex-specific auditory and visual attention impairments in teens.
The researchers found significant, relatively consistent effects from maternal
marijuana exposure on CNS function in the offspring. Prenatal marijuana exposure
predicted higher rates of attention deficits and impulsivity at age 3, 6, and 14
years. It also was linked with poorer academic performance and higher rates of
delinquency at ages 6, 10, 14, and 16 years.
In 10-year-olds, prenatal exposure to marijuana was linked with marginally more
depressive symptoms and poor performance on memory and visual planning tests.
At age 14 years, exposure to marijuana in the womb predicted problems with
sustained attention, cognitive flexibility, and response suppression. Marijuana
use by their mothers was a significant predictor of age of onset of marijuana
use and of frequency of marijuana use in the 14-year-olds.
Prenatal exposure to marijuana leads to deficits in mood, aggression, cognitive
development, working memory, and, as secondary results, higher rates of
substance use, sexual behavior.
Another study extends preclinical findings and suggests that in humans, prenatal
and adolescent exposure to nicotine exerts sex-specific harmful effects on
auditory and visual attention in adolescents.
In the female adolescents, exposure to nicotine either prenatally or from
current smoking was associated with reductions in both auditory and visual
attention performance accuracy. In male adolescents, the nicotine exposure was
linked to decreases in auditory attention but not visual attention.
Activation of brain areas that support auditory attention was greater in
adolescents with prenatal or adolescent exposure to tobacco smoke relative to
adolescents without such exposure."
November 5, 2007
Q "I
take antidepressants and am in psychotherapy for depression. My sleep is lousy,
and I wake up a lot, often coughing because of my dry throat. I am
guessing that this is from the medication but I wondered if I had sleep apnea."
A
Your physician can help you determine whether you
have sleep apnea, and you find this interesting: "Continuous positive airway
pressure (CPAP) leads to a sustained improvement in symptoms of depression in
patients with obstructive sleep apnea (OSA.
Symptoms that might otherwise be ascribed to depression -- feelings of sadness,
discouragement about the future, feelings of excessive personal failures,
perceived decreases in self-confidence, a sense of being overly self-critical,
the inability to derive pleasure from things, and even suicidal ideation -- may
at times be attributable to OSA, an easily treatable medical illness.
People with OSA are often depressed. Cclinicians noted a statistically
significant improvement in Beck Depression Inventory scores 4 to 6 weeks after
initiation of in-home CPAP therapy.
Their latest assessment of these patients conducted about 1 year after the
initiation of CPAP shows that ongoing CPAP therapy is associated with sustained
improvement in depressive symptoms.
At least some patients being treated with antidepressant medications -- those
whose symptoms are due to OSA -- might be better served with CPAP therapy. It
remains "incompletely understood" how CPAP therapy lessens depressive symptoms.
Whether relief of the obstructive respiratory events with CPAP might ameliorate
the symptoms by improving sleep continuity, by ameliorating the adverse effects
of various neurotransmitters (catecholamines or cortisol-related peptides), by
alleviating the adverse effects of any attendant hypoxemia, or by a mechanism as
yet unknown, cannot be determined."
J Clin Sleep Med 2007;3:631-635
October 29, 2007
Q
"Can deep brain stimulation work for things other than conversion disorder...I
read about it being used for conversion?"
A
"Deep brain stimulation (DBS) of the nucleus accumbens was associated with
remission of alcohol dependence in a man with severe anxiety disorder and
secondary depression.
Researchers used bilateral DBS of the nucleus accumbens in the patient, in an
attempt to treat his severe anxiety disorder and secondary depressive disorder.
DBS had no beneficial effect on the patient's primary disorder, but there was a
remarkable change in alcohol dependence.
After only a month of DBS, the patient did not consume alcohol on most days, no
longer drank excessively, and reduced his consumption to 1 to 2 drinks on days
when he did consume alcohol.
A year after starting DBS, the patient only occasionally consumes alcohol. He
claims to have lost the desire to drink and says the pressing need to consume
alcohol has almost disappeared. A relatively general consensus prevails that the
mesocorticolimbic system, especially the nucleus accumbens, is to be viewed as
the primary area impaired by psychotropic substances and consequently as the
neural substrate for substance dependencies."
J Neurol Neurosurg Psychiatry 2007;78:1152-1153
October 22, 2007
Q "I
am exhausted all the time, and my wife is as well, and I know that this is not
healthy. What are the current thoughts on the causes of sleep loss or
whatever it is called?"
A
You might find this research interesting: "Sleep insufficiency is more common in
households with children. Approximately 45 million American adults are not
sleeping enough to be fully alert the next day, the authors report.
Researchers found that the presence of children in the household is associated
with sleep insufficiency and that both married and unmarried women with children
were more likely to report sleep insufficiency than their male counterparts;
sleep insufficiency did not vary significantly between men and women who were
unmarried and had no children. The data showed that women with children are most
likely of all to suffer from sleep insufficiency.
Previous research suggests that sleep insufficiency is associated with the
symptoms and treatment outcomes of chronic conditions, including obesity,
diabetes, and sleep apnea. Parental status may also be important in reducing the
burden of chronic disease."
October 15, 2007
Q "My
son is disabled, and we are seeking permanent disability for him for his
depression. Do you think this is generally the best idea?"
A
"A program of supported employment was more effective than vocational training
for patients with severe mental illness. Over an 18-month follow-up, 55% of
patients assigned to an individual placement and support program, vs 28% of
patients assigned to traditional vocational services, obtained competitive
employment, without mental relapse.
It is very important for clinicians to be aware that they are not risking the
fragile health of their patients by getting them back to work. We should take
more risks in encouraging even very disabled patients to seek work with
assistance.
Unemployment rates for people with severe mental illness are as high as 95%
Traditional rehabilitation, or the "train-and-place" model, in which patients
are trained in job skills to prepare them for work, is the most widespread
method of job placement, but it has had very limited success, and many patients
obtain work only in sheltered workshops.
On the other hand, "place-and-train" employment intervention emphasizes direct
job placement, often in simple, entry-level occupations. The most intensively
studied place-and-train method, and the recommended practice in the United
States, is the individual placement and support method, which includes rapid job
search according to patient preference along with continued support to the
patient and employer.
Europe has less of a "hire-and-fire" culture than the United States, and its
more generous welfare system might create a "benefit trap," where patients could
face real or perceived financial disincentives for returning to work."
Lancet. 2007;370:1146-1152 Abstract,1108-1109
October 8, 2007
Q "Can
the disease called anorexia actually be a bodily addiction?"
A
"Scientists have found that anorexia and the use of
MDMA, the psychogenic compound in the club-drug ecstasy, share a common
signaling pathway in the brain -- a finding that may help explain the addictive
nature of anorexia and other eating disorders.
Anorexia-like behavior in mice is produced by altering the signaling of neuronal
messengers within the nucleus accumbens (NAc) -- a brain structure involved in
reward. Direct stimulation of serotonin 5-HT4 receptors, which are known to play
a role in addictive behavior, diminishes the amount of food fed mice consume
(increased satiety) and diminishes the physiological drive to eat in
food-deprived mice.
Stimulation of 5-HT4R also increases NAc levels of mRNA encoding the anorectic
peptide CART (cocaine- and amphetamine-regulated transcript (CART) in both fed
and food-deprived mice.
5-HT4R is required for the anorectic effect of MDMA as well as for the MDMA-induced
enhancement of CART mRNA expression in the NAc.
Direct injection of CART peptide into the NAc reduces food intake, whereas
injection of CART small interfering RNA (siRNA) increases food consumption.
Injection of CART siRNA into the NAc interfered with both 5-HT4R-induced and
MDMA-induced anorexia."
PNAS Early Edition 2007
October 1, 2007
Q
"We have begun a screening program at work to determine who is depressed. This
was recommended to us. Do you feel that this will be cost effective?"
A
Yes, and you may wish to read this: "A new
study found that a program of telephone depression screening, vigorous outreach,
and care management of depressed workers not only improved clinical outcomes but
also improved workplace outcomes of job retention, sickness absence, and work
productivity.
People who received the intervention were about 40% more likely to recover from
depression, and they also were about 70% more likely to be working (retaining
employment) at the end of the 12-month intervention period. Among those who were
working, employees in the intervention group worked on average about 2 more
hours per week than those who were in the usual-care study arm," he added.
Studies estimate that the US economy loses tens of billions of dollars each year
due to employee depression, mainly through lost productivity. Organized
depression screening and enhanced care programs have been shown to significantly
improve outcomes.
Measurements of depression severity were lower in the intervention group than in
the usual-care group. Patients in the intervention group were more likely than
those in the usual-care group to recover from depression and to retain their
jobs.
It's important for clinicians to treat patients with depression adequately,
because not only does this improve clinical outcomes, it also improves patients'
ability to work, which is a very important component of people's lives.
While formal estimates of cost-effectiveness are pending, it appears to be in
the business interests of many employers to implement such programs to protect
their investments in the retention and productivity of workers they have hired
and trained."
JAMA. 2007;298:1401-1411 Abstract,1451-1452.
|
|
Clinical
Services | Educational
Services | OnLine
Referral |
Contact Us |
|
©2007 David B. Adams,
Ph.D. |
|